Spherical gaseous time projection chamber detectors, known also as spherical proportional counters, are widely used today for the search of rare phenomena such as weakly interacting massive particles. In principle such a detector exhibits a number of essential features for the search of neutrinoless double beta decay (ββ0ν). A ton scale experiment using a spherical gaseous time projection chamber could cover a region of parameter space relevant for the inverted mass hierarchy in just a few years of data taking. In this context, the first point to be addressed, and the major goal of the R2D2 R&D effort, is the energy resolution. The first results of the prototype, filled with argon at pressures varying from 0.2 to 1.1 bar, yielded an energy resolution as good as 1.1% FWHM for 5.3 MeV α tracks having ranges from 3 to 15 cm. This is a milestone that paves the way for further studies with xenon gas, and the possible use of this technology for ββ0ν searches.
The measurement of neutrino magnetic moment larger than
10-19
μB
would be a clear signature of physics beyond the
standard model other than the existence of massive Dirac
neutrinos. The use of a spherical proportional counter detector
filled with gas at 40 bar located near a nuclear reactor would be a
simple way to perform such a measurement exploiting the developments
made on such a technology for the search of dark matter and
neutrinoless double beta decay. Different targets can be used just
by replacing the gas: xenon, CF4 and argon were compared and the
sensitivity in one year of data taking could reach the level of
4.3 × 10-12
μB
, 6.5 × 10-12
μB
, and
8.5 × 10-12
μB
, respectively.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.